We are live on ! Find out more
Globeflex Capital

Globeflex Capital Portfolio holdings

AUM $783M Turnover 28.73%
1-Year Est. Return 81.58%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
Cap. Flow
-$22.1M
Cap. Flow %
-2.82%
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62
Avg Time Held
1.9 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.4 years

Top Buys

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$6.96M
2
MYRG icon
MYR Group
MYRG
+$4.57M
3
DRS icon
Leonardo DRS
DRS
+$4.16M
4
SMTC icon
Semtech
SMTC
+$3.99M
5
P icon
Everpure Inc
P
+$3.43M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Industrials 19.78%
3 Financials 17.73%
4 Healthcare 17.14%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
THC icon
26
Tenet Healthcare
THC
$21.7B
$6.76M 0.86%
36,149
-86
-0.2% -$15.8K
2024 Q1
9 quarters
CIEN icon
27
Ciena
CIEN
$45.5B
$6.7M 0.86%
+13,648
New +$6.96M
2026 Q2
0 quarters
CMRE icon
28
Costamare
CMRE
$1.71B
$6.65M 0.85%
474,374
– –
2017 Q1
37 quarters
TCMD icon
29
Tactile Systems Technology
TCMD
$522M
$6.62M 0.85%
222,298
– –
2022 Q4
14 quarters
ARCO icon
30
Arcos Dorados Holdings
ARCO
$1.42B
$6.57M 0.84%
815,609
– –
2021 Q4
18 quarters
DXPE icon
31
DXP Enterprises
DXPE
$2.71B
$6.51M 0.83%
38,564
+848
+2% +$134K
2023 Q2
12 quarters
UHS icon
32
Universal Health Services
UHS
$10.4B
$6.2M 0.79%
41,697
-2,841
-6% -$462K
2024 Q1
9 quarters
MYRG icon
33
MYR Group
MYRG
$4.4B
$6.04M 0.77%
12,073
+11,137
+1,190% +$4.57M
2026 Q1
1 quarter
AFRM icon
34
Affirm
AFRM
$24.8B
$5.99M 0.76%
73,405
+17,366
+31% +$1.13M
2026 Q1
1 quarter
KNSA icon
35
Kiniksa Pharmaceuticals
KNSA
$7.25B
$5.97M 0.76%
93,396
– –
2024 Q2
8 quarters
PAHC icon
36
Phibro Animal Health
PAHC
$1.58B
$5.94M 0.76%
189,224
-20,815
-10% -$878K
2017 Q1
37 quarters
VVX icon
37
V2X
VVX
$2.52B
$5.94M 0.76%
79,622
+29,556
+59% +$2.2M
2016 Q4
38 quarters
MEDP icon
38
Medpace
MEDP
$18.2B
$5.81M 0.74%
10,963
-1,946
-15% -$898K
2018 Q3
31 quarters
DT icon
39
Dynatrace
DT
$16.7B
$5.72M 0.73%
130,206
-591
-0.5% -$23K
2024 Q4
6 quarters
NVT icon
40
nVent Electric
NVT
$20.4B
$5.67M 0.72%
33,404
– –
2025 Q1
5 quarters
TPC icon
41
Tutor Perini Cor
TPC
$4.2B
$5.56M 0.71%
66,959
– –
2025 Q2
4 quarters
ONTO icon
42
Onto Innovation
ONTO
$9.9B
$5.51M 0.7%
14,549
+1,799
+14% +$509K
2026 Q1
1 quarter
AA icon
43
Alcoa
AA
$10.3B
$5.42M 0.69%
103,952
-106
-0.1% -$7.1K
2026 Q1
1 quarter
CCNE icon
44
CNB Financial Corp
CCNE
$1.05B
$5.4M 0.69%
160,083
– –
2025 Q3
3 quarters
RDVT icon
45
Red Violet
RDVT
$1.28B
$5.28M 0.67%
82,855
+42
+0.1% +$1.99K
2024 Q2
8 quarters
LYTS icon
46
LSI Industries
LYTS
$746M
$5.19M 0.66%
195,394
+1,544
+0.8% +$35.7K
2022 Q4
14 quarters
PRCH icon
47
Porch Group
PRCH
$2.35B
$5.15M 0.66%
342,376
– –
2026 Q1
1 quarter
MWA icon
48
Mueller Water Products
MWA
$3.56B
$5.09M 0.65%
197,096
-10,540
-5% -$282K
2024 Q2
8 quarters
SMTC icon
49
Semtech
SMTC
$11.9B
$4.94M 0.63%
+30,550
New +$3.99M
2026 Q2
0 quarters
MCY icon
50
Mercury Insurance
MCY
$5.67B
$4.9M 0.63%
45,964
+13,831
+43% +$1.36M
2025 Q3
3 quarters

Similar funds

Globeflex Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Financials.

  • Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
  • Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
  • Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
  • Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
  • Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
  • Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
  • Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.